The author of the article:
It was published on February 19, 2025 • 4 minutes read
Article content
- Mr. David is a retirement homes from the Philip's supervisory council after his third consecutive term.
- Mr. Bob White suggested as a new member of the Supervision Council.
- Mrs. Endra Nuwi and Mrs. Choa Suk Kong suggested that she be reset as members of the Supervisory Council.
- Marnix Van Ginneken has suggested resetting a member of the Philips Board of Directors.
Article content
Article content
February 19, 2025
Amsterdam, Netherlands – Royal Philips (NYSE: PHG, AEX: Phia), The World Leader in Health Technology, today announced the dates of the proposed supervisory council and re -appointment, and the proposed management re -setting board.
Advertisement 2
This announcement has not yet been downloaded, but your article is continuing below.
Article content
Mr. David Bewits (the British/American, 1953) will retire from the Philip's supervisory council at the end of the annual general meeting of the shareholders 2025. Mr. Bewits joined the Supervision Council in 2015 and presented three consecutive periods. He has been head of the Quality and Organizational Committee since May 2020.
The Supervision Council for the annual general meeting of shareholders 2025 will propose the appointment of Mr. Bob White (America, 1962) as a new member of the Supervisory Council. After his appointment, Mr. White Al -Sayed will succeed homes as head of the Quality and Organizational Committee.
The recommendation on this date depends on Mr. White's wide experience and expertise in the health technology sector, which covers the United States, Europe, Asia and the Pacific, and its rich record in leading growth and enhancing innovation. Until 2024, Mr. White held the position of Executive Vice President at Medrtonic, after a successful career in Gealthcare, IBM and other leading health technology companies.
The Supervision Council will propose to the re -setting up Mrs. Andra Nawi (American, 1955) and Mrs. Choa Suk Kong (Singapore, 1957) as members of the Supervision Council.
Article content
Advertising 3
This announcement has not yet been downloaded, but your article is continuing below.
Article content
This will be recommended to be re -appointed in view of its valuable contributions to the supervisory council, and since global business leaders who prove their record are strong records in areas ranging from consumer products to technology, digitization, finance and Asia. Their experience and leadership will remain of great value as Philips offers more progress on its journey to improve health care and the impact of driving with care for patients, people and the planet.
Moreover, the Supervisory Council will recommend that Mr. Marnex Van Jennikin as a member of the Philips Board of Directors, while recognizing his strong leadership, his deep knowledge of Philips and his extensive experience in corporate governance, as well as the important role he played in the Executive Committee.
“On behalf of the supervisory council and the board Chairman of the Quality and Organizational Committee. Deep experience in health technology.
Advertising 4
This announcement has not yet been downloaded, but your article is continuing below.
Article content
Mr. Sijbesma added: “With my fellow members of the Supervisory Council, we recommend that Marnix Van Ginneken. I am very pleased that he is still available as a member of the Board Commercial to enable better care for more people, while fully fulfilling the capabilities Through the VILIPS strategy to create a value.
More information will be published about the annual general meeting 2025, which will be held on May 8, 2025, in a timely manner. Additional information can be found about the Board of Directors and the Supervision Council here.
For more information, please contact:
Michael Fox
Philips Foreign Relations International
Phone: +31 61486 9261
Email: michael.fuchs@philips.com
Doreen Dano
Philips relations for the investor
Phone: +31 20 59 77055
Email: Dorin.danu@philips.com
About Royal Phillips
Royal Philips (NYSE: Phg, AEX: Phia) is a leading health technology company that focuses on improving people's health and luxury through glorious innovation. The innovation centered around the patient and people in Philips enhances advanced technology, clinical visions and deep consumers to provide personal health solutions to consumers and occupational health solutions for health care providers and their patients in the hospital and home. Its headquarters is located in the Netherlands, a leading company in diagnostic photography, ultrasound, photo -directed treatment, institutional monitoring and informational, as well as in personal health. Philips has established 2024 sales of 18 billion euros and employs approximately 6,7800 employees with sales and services in more than 100 countries.
News can be found in Philips in www.philips.com/newscentter.
Topical data
This version contains some aspiration data regarding financial conditions, operations results, philips and some philips plans and goals regarding these elements. Examples of aspiration data include data on strategy, sales growth estimates, immigration and services before benefits, taxes, future depreciation, future developments in Philips organic businesses, completing acquisitions and abstraction. By its nature, these data involve the risks and uncertainty because it relates to future events and circumstances and there are many factors that may cause actual results and developments that differ financially from those that are expressed or implicit these phrases.
Attachments
Article content